NY AG Says Actavis Trying To Shield Namenda Monopoly
New York's attorney general pushed the Second Circuit to continue forcing Actavis PLC to sell the immediate-release version of its dementia drug Namenda, which is allegedly getting pulled to illegally keep...To view the full article, register now.
Already a subscriber? Click here to view full article